Trial Profile
Recombinant human thrombopoietin in combination with cyclosporin A as a novel therapy in corticosteroid-resistant primary immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 21 Dec 2015 New trial record